SolithroMycin
760981-83-7
Shanghai
Bottle
2024-12-28
Inhibitor,API
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Solithromycin
Other Name:2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone,1-[4-[4-(3-aminophenyl)-1H-1,2,3-triazol-1-yl]butyl]-4-ethyl-7-fluorooctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-,(3aS,4R,7S,9R,10R,11R,13R,15R,15aR)-;(3aS,4R,7S,9R,10R,11R,13R,15R,15aR)-1-[4-[4-(3-Aminophenyl)-1H-1,2,3-triazol-1-yl]butyl]-4-ethyl-7-fluorooctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-10-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-2H-oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone;CEM 101;Solithromycin;OP 1068;Solithera
CAS No.:760981-83-7
Molecular Formula:C43H65FN6O10
InChIKeys:InChIKey=IXXFZUPTQVDPPK-ZAWHAJPISA-N
Molecular Weight:845.0
Exact Mass:845.01
UNII:9U1ETH79CK
ATC Code:J - Antiinfectives for systemic use
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Inhibitor,API
-
Location:
No.455 Zhengying Road, QingPu, Shanghai
-
Payment Terms:
D/P,TT against B/L draft before shipment
-
Average lead Time:
360
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product